UBS AG Q3 2026 Net Profit Jumps 80% to USD 2.3bn; CET1 Ratio Rises to 14.5%
AMUB sits 26% above its 52-week low of $17.653 on light trading volume (0.1× avg).
Summary
UBS AG reported third-quarter 2026 net profit of USD 2,315m, up 79.7% year-on-year, with year-to-date profit of USD 7,028m and a CET1 capital ratio of 14.5%.
Key Events · Earnings and Guidance · AMUB
-
Q3 Net Profit Nearly Doubles
Net profit attributable to shareholders was USD 2,315m for the quarter ended 30 September 2026, up 79.7% from USD 1,288m a year earlier.
-
Year-to-Date Profit USD 7,028m
First nine months of 2026 net profit reached USD 7,028m versus USD 3,508m in the same period of 2025, helped by net fee and commission income of USD 22,741m (versus USD 20,253m) and operating expenses down to USD 31,140m from USD 32,148m.
-
Capital Ratios Above Requirements
CET1 capital ratio was 14.5% against a 10.83% requirement, and the CET1 leverage ratio was 4.5% against a 3.58% requirement, as of 30 September 2026.
-
USD 4,500m Supplementary Dividend Paid
The Extraordinary General Meeting on 21 October 2026 approved a supplementary 2025 dividend of USD 4,500m, paid to shareholder UBS Group AG the following day.
Analysis · AMUB · Finance
Third-quarter profit of USD 2,315m at UBS AG is nearly double the USD 1,288m earned a year earlier, lifting year-to-date net profit to USD 7,028m from USD 3,508m. Higher fee and commission income (USD 22,741m year-to-date versus USD 20,253m) and lower operating expenses (USD 31,140m versus USD 32,148m) drove the improvement, pushing the cost/income ratio down to 76.5% from 88.7%. Capital remains comfortably above requirements, with a 14.5% CET1 ratio against a 10.83% requirement and a 4.5% CET1 leverage ratio against 3.58%. The main overhang is litigation: provisions for litigation, regulatory and similar matters still total USD 2,010m, and UBS estimates a further USD 0bn to USD 1.3bn of possible losses not yet provided for. Note this is the UBS AG entity report; the parent UBS Group AG reported a higher net profit of USD 2,700m for the quarter, mainly due to purchase price allocation effects from the Credit Suisse acquisition that do not apply at the UBS AG level.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.5% of the 1494 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMUB was trading at $22.21 on NYSE in the Finance sector. The 52-week trading range was $17.65 to $24.44. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.